PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1230
https://www.valueinhealthjournal.com/article/S1098-3015(12)02943-9/fulltext
Title :
PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02943-9&doi=10.1016/j.jval.2012.08.1230
First page :
A415
Section Title :
Cancer
Open access? :
No
Section Order :
731